Skip to main content
Medical information Clinical review pending

Genetic Testing

AIRE Gene Autoimmune Polyendocrinopathy Syndrome Type 1 Genetic Test

Genetic test using Next Generation Sequencing (NGS) to analyze the AIRE gene, identifying potential risks for Autoimmune Polyendocrinopathy Syndrome Type 1 (APS-1).

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube). Confirm with the laboratory before booking.
Results
Approximately 3 to 4 weeks. Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required, but a clinical history review and genetic counseling session, including a family pedigree chart, are necessary before testing.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the AIRE Gene Autoimmune Polyendocrinopathy Syndrome Type 1 Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Symptoms suggestive of Autoimmune Polyendocrinopathy Syndrome Type 1 (APS-1).
  • ✓Family history of APS-1 or related autoimmune disorders.
  • ✓Diagnosis of chronic mucocutaneous candidiasis.
  • ✓Diagnosis of autoimmune hypoparathyroidism.
  • ✓Diagnosis of autoimmune adrenal insufficiency (Addison's disease).
  • ✓Evaluation of multiple autoimmune endocrine conditions.
02

In plain language

What this test helps you understand

Identifies genetic mutations in the AIRE gene associated with Autoimmune Polyendocrinopathy Syndrome Type 1 (APS-1), aiding in diagnosis and risk assessment.
The AIRE Gene Autoimmune Polyendocrinopathy Syndrome Type 1 NGS Genetic DNA Test is an advanced diagnostic tool used to examine the AIRE gene. This gene is important for the proper functioning of the immune system. Identifying variations in this gene can help understand a person's predisposition to developing autoimmune disorders, particularly Autoimmune Polyendocrinopathy Syndrome Type 1 (APS-1).

This test utilizes Next Generation Sequencing (NGS) technology, which allows for a detailed analysis of the AIRE gene to detect mutations. Understanding these genetic factors can provide valuable information for healthcare providers in managing patient health and potential risks associated with APS-1.

Individuals experiencing symptoms suggestive of autoimmune disorders or those with a family history of such conditions may benefit from this test. It can aid in early detection, informed treatment decisions, and personalized management strategies. Genetic counseling is recommended to help interpret the results and discuss their implications.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required, but a clinical history review and genetic counseling session, including a family pedigree chart, are necessary before testing.
SampleBlood sample (EDTA tube). Confirm with the laboratory before booking.
MethodologyNext Generation Sequencing (NGS) analysis of the AIRE gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes specific regions of the AIRE gene. It may not detect all possible mutations. Results should be interpreted alongside clinical information. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

APS-1 is a rare genetic disorder characterized by the development of multiple autoimmune conditions, often including chronic mucocutaneous candidiasis, hypoparathyroidism, and adrenal insufficiency.
Individuals with symptoms of APS-1, such as persistent fungal infections, low calcium levels, or adrenal problems, or those with a family history of the condition should consider this test.
The test involves analyzing a blood sample using Next Generation Sequencing (NGS) to look for mutations in the AIRE gene.
Results indicate the presence or absence of specific mutations in the AIRE gene. Genetic counseling is recommended to understand the implications of the results.
A genetic counseling session is recommended before testing and to discuss results. Please inquire about scheduling and associated costs.
The turnaround time is approximately 3 to 4 weeks, but this can vary. Confirm with the laboratory before booking.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp